"Duke Asthma, Allergy, and Airway Center is an interdisciplinary center dedicated to research, education and clinical care for patients with asthma, allergic diseases and airway disease. This includes lung, upper airway and skin allergies, Chronic Obstructive Pulmonary Disease (COPD), bronchiectasis and cystic fibrosis."

During the past decade, Duke Asthma Allergy and Airway Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Duke Asthma Allergy and Airway Center" #1 sponsor was "Duke University" with 5 trials, followed by "Bastiaan Driehuys" with 3 trials sponsored, "Shire" with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Nivalis Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duke Asthma Allergy and Airway Center" #1 collaborator was "Dyax Corp." with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Duke Asthma Allergy and Airway Center" are "Asthma" (7 trials), "Obesity" (3 trials), "Hereditary Angioedema (HAE)" (2 trials), "Asthma, Allergic" (1 trials) and "Bariatric Surgery Candidate" (1 trials). Many other conditions were trialed in "Duke Asthma Allergy and Airway Center" in a lesser frequency.

Most popular intervention types in "Duke Asthma Allergy and Airway Center" are "Drug" (9 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Active" (1 trials), "Azithromycin" (1 trials), "Bevespi Aerosphere" (1 trials) and "DX-2930" (1 trials). Other intervention names were less common.

The vast majority of trials in "Duke Asthma Allergy and Airway Center" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Duke Asthma Allergy and Airway Center". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Duke Asthma Allergy and Airway Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Duke Asthma Allergy and Airway Center, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".